Use of medications in women with triple-negative breast cancer between 2018 and 2019 in a Brazilian public hospital: a retrospective study
Abstract Objective: To describe the profile of medication use in women with triple-negative breast cancer treated between 2018 and 2019 in a Brazilian public hospital. Methods: Descriptive and retrospective study, with data obtained from the Hospital Cancer Registry and physical and electronic med...
Saved in:
| Main Authors: | Monique Cristine da Silva Pires, Mario Jorge Sobreira-da-Silva, Patrícia Portella de Araújo, Maely Peçanha Favero Retto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministério da Saúde do Brasil
2025-02-01
|
| Series: | Epidemiologia e Serviços de Saúde |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-96222025000100200&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry
by: Tomoe Taji, et al.
Published: (2025-06-01) -
The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
by: Chikako Funasaka, et al.
Published: (2025-01-01) -
Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
by: Ruiliang Chen, et al.
Published: (2024-12-01) -
Effect of HER2-low expression on the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer
by: Lin-Yu Xia, et al.
Published: (2025-06-01) -
Comprehensive genomic profiling can predict response to neoadjuvant chemotherapy in triple-negative breast cancer
by: Monika Drobniene, et al.
Published: (2025-04-01)